PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Recent findings in molecular pathology suggest that genetic translocation and/or overexpression of oncoproteins is important in salivary gland tumorigenesis and diagnosis. We investigated PLAG1, SOX10, and Myb protein expression in various salivary gland neoplasm tissues. Methods: A total of 113 cases of surgically resected salivary gland neoplasms at the National Cancer Center from January 2007 to March 2017 were identified. Immunohistochemical staining of PLAG1, SOX10, and Myb in tissue samples was performed using tissue microarrays. Results: Among the 113 cases, 82 (72.6%) were benign and 31 (27.4%) were malignant. PLAG1 showed nuclear staining and normal parotid gland was not stained. Among 48 cases of pleomorphic adenoma, 29 (60.4%) were positive for PLAG1. All other benign and malignant salivary gland neoplasms were PLAG1-negative. SOX10 showed nuclear staining. In normal salivary gland tissues SOX10 was expressed in cells of acinus and intercalated ducts. In benign tumors, SOX10 expression was observed in all pleomorphic adenoma (48/48), and basal cell adenoma (3/3), but not in other benign tumors. SOX10 positivity was observed in nine of 31 (29.0%) malignant tumors. Myb showed nuclear staining but was not detected in normal parotid glands. Four of 31 (12.9%) malignant tumors showed Myb positivity: three adenoid cystic carcinomas (AdCC) and one myoepithelial carcinoma with focal AdCC-like histology. Conclusions: PLAG1 expression is specific to pleomorphic adenoma. SOX10 expression is helpful to rule out excretory duct origin tumor, but its diagnostic value is relatively low. Myb is useful for diagnosing AdCC when histology is unclear in the surgical specimen.
Abstract
Background: Recent findings in molecular pathology suggest that genetic translocation and/or overexpression of oncoproteins is important in salivary gland tumorigenesis and diagnosis. We investigated PLAG1, SOX10, and Myb protein expression in various salivary gland neoplasm tissues. Methods: A total of 113 cases of surgically resected salivary gland neoplasms at the National Cancer Center from January 2007 to March 2017 were identified. Immunohistochemical staining of PLAG1, SOX10, and Myb in tissue samples was performed using tissue microarrays. Results: Among the 113 cases, 82 (72.6%) were benign and 31 (27.4%) were malignant. PLAG1 showed nuclear staining and normal parotid gland was not stained. Among 48 cases of pleomorphic adenoma, 29 (60.4%) were positive for PLAG1. All other benign and malignant salivary gland neoplasms were PLAG1-negative. SOX10 showed nuclear staining. In normal salivary gland tissues SOX10 was expressed in cells of acinus and intercalated ducts. In benign tumors, SOX10 expression was observed in all pleomorphic adenoma (48/48), and basal cell adenoma (3/3), but not in other benign tumors. SOX10 positivity was observed in nine of 31 (29.0%) malignant tumors. Myb showed nuclear staining but was not detected in normal parotid glands. Four of 31 (12.9%) malignant tumors showed Myb positivity: three adenoid cystic carcinomas (AdCC) and one myoepithelial carcinoma with focal AdCC-like histology. Conclusions: PLAG1 expression is specific to pleomorphic adenoma. SOX10 expression is helpful to rule out excretory duct origin tumor, but its diagnostic value is relatively low. Myb is useful for diagnosing AdCC when histology is unclear in the surgical specimen.
참고문헌 (29)
- Rosai J, "Rosai and Ackerman's surgical pathology" (2011), Mosby
- Griffith CC, "New Developments in salivary gland pathology : clinically useful ancillary testing and new potentially targetable molecular alterations", Arch Pathol Lab Med, 141, pp.381~395 (2017)
- Van Dyck F, "PLAG1, the prototype of the PLAG gene family : versatility in tumour development(review)", Int J Oncol, 30, pp.765~774 (2007)
- Zatkova A, "Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma", Genes Chromosomes Cancer, 39, pp.126~137 (2004)
- Dabbs DJ, "Diagnostic immunohistochemistry : theranostic and genomic applications" (2018), Saunders
- Ohtomo R, "SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors : a clue to the histogenesis for tumor diagnosis", Mod Pathol, 26, pp.1041~1050 (2013)
- Brill LB 2nd, "Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms", Mod Pathol, 24, pp.1169~1176 (2011)
- Kim SH, "Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma", Histol Histopathol, 33, pp.589~596 (2018)
- El-Naggar AK, "WHO classification of head and neck tumors" (2017), IARC Press
- Vasef M, "Diagnostic pathology : molecular oncology" (2016), Elsevier
- Katabi N, "PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma : a comparative study with PLAG1 genetic abnormalities", Histopathology, 72, pp.285~293 (2018)
- Han N, "Evaluation of fibroblast growth factor receptor 2 expression, heterogeneity and clinical significance in gastric cancer", Pathobiology, 82, pp.269~279 (2015)
- Martins C, "PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma : a combined study using chromosome banding, in situ hybridization and immunocytochemistry", Mod Pathol, 18, pp.1048~1055 (2005)
- Rotellini M, "Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors", Appl Immunohistochem Mol Morphol, 22, pp.390~394 (2014)
- de Brito BS, "Loss of expression of Plag1in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma", Hum Pathol, 57, pp.152~159 (2016)
- Avadhani V, "PLAG1 : an immunohistochemical marker with limited utility in separating pleomorphic adenoma from other basaloid salivary gland tumors", Acta Cytol, 60, pp.240~245 (2016)
- Matsuyama A, "Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland : a molecular genetic and immunohistochemical study", Virchows Arch, 458, pp.583~592 (2011)
- Deen M, "A novel PLAG1-RAD51L1 gene fusion resulting from a t(8;14)(q12;q24)in a case of lipoblastoma", Cancer Genet, 206, pp.233~237 (2013)
- Abi Habib W, "Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction", Genet Med, 20, pp.250~258 (2018)
- Bartlett JM, "Molecular pathology : a practical guide for the surgical pathologist and cytopathologist" (2015), Cambridge University Press
- Bahrami A, "PLAG1 alteration in carcinoma ex pleomorphic adenoma : immunohistochemical and fluorescence in situ hybridization studies of 22 cases", Head Neck Pathol, 6, pp.328~335 (2012)
- Mills SE, "Histology for pathologists" (2012), Lippincott Williams & Wilkins
- Hsieh MS, "SOX10-positive salivary gland tumors : a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma", adenocarcinoma, and a subgroup of mucoepidermoid carcinoma, 2016, pp.56, 134~142
- Mitani Y, "Comprehensive analysis of the MYBNFIB gene fusion in salivary adenoid cystic carcinoma : incidence, variability, and clinicopathologic significance", Clin Cancer Res, 16, pp.4722~4731 (2010)
- von Holstein SL, "Adenoid cystic carcinoma of the lacrimal gland : MYB gene activation, genomic imbalances, and clinical characteristics", Ophthalmology, 120, pp.2130~2138 (2013)
- Chen TY, "Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement", Eye (Lond), 31, pp.720~725 (2017)
- North JP, "Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma", Am J Surg Pathol, 39, pp.1347~1356 (2015)
- Poling JS, "MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid cystic carcinoma than MYB labeling by FISH", Am J Surg Pathol, 41, pp.973~979 (2017)
- Ramsay RG, "MYB function in normal and cancer cells", Nat Rev Cancer, 8, pp.523~534 (2008)